Pharma Industry News

FCBA Program on IPR Estoppel

The Federal Circuit Bar Association (FCBA) will be offering a program on "The Evolving Scope of IPR Estoppel" on March 29, 2018 from 1:00 pm to 2:00 pm (EST) at the FCBA office in Washington, DC. Eldora Ellison of Sterne Kessler Goldstein & Fox, PLLC will moderate a panel consisting of Brian Walsh of Bristol-Myers Squibb Company, Andrew Trask of Google LLC, and Jonathan Strang of Latham & Watkins LLP. The panel will provide an overview of the current state of estoppels following IPRs, and also consider the impact that the evolution of the application of the AIA's estoppel provisions…Original Article

About the author

David Miller

a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.

[mwai_chat window="true" fullscreen="true"]